In the midst of an unprecedented rise in Covid cases, the Supreme Court has urged the Center and states “to consider imposing a lockdown to break the chain in the interest of public welfare”. It likewise guided the central government to re-evaluate its initiatives and protocols, including the accessibility of oxygen, availability and pricing of vaccines, and availability of essential drugs at affordable prices.
A three-member apex court bench, including Justice D Y Chandrachud, Justice L Nageswara Rao and Justice Ravindra Bhat said, “We are cognisant of the socio-economic impact of a lockdown, specifically, on the marginalized communities… thus, in case the measure of a lockdown is imposed, arrangements must be made beforehand to cater to the needs of these communities.”
In addition, the top court also asked the Center to construct a national policy within two weeks on admissions to hospitals in lieu of the second wave of coronavirus pandemic. The Supreme Court further informed that and said that no patient shall be denied hospitalisation or essential drugs in any state for lack of local residential proof. The decision came after people are struggling to get adequate healthcare facilities in the hospitals.
The country has been recording over 3 lakh cases for the past few weeks. In the last 24 hours, it reported over 3.68 fresh COVID-19 cases. The 3,68,147 new infections take active COVID cases in India to 34,13,642. Meanwhile, 3,417 people died due to coronavirus, taking the total death toll in India from the pandemic to 2,18,959.
The nation has been recording more than 3 lakh cases for the past few weeks with 3,417 casualties taking the total death toll in India to 2,18,959.
On April 20, the Centre had revised its vaccine policy and asserted it would procure 50 per cent of the Covishield and Covaxin supplies at Rs 150 per dose and allowed states and private hospitals to procure 50 per cent of the quota on their own. The vaccination drive opens for all above 18 years from May 1.
On April 20, the Center had reexamined its vaccine policy and attested it would get 50% of the Covishield and Covaxin supplies at Rs 150 per dose and permitted states and private medical hospitals to secure 50% of the quota on their own. The vaccination drive opens for all above 18 years from May 1.
After revising its policy, SII, the manufacturer of Covishield, has said that its expense for states will be Rs 400 per dose and Rs 600 per shot for private hospitals. for each went for private emergency clinics. Bharat Biotech’s covaxin can be secured by states and private hospitals channels at Rs 600 and Rs 1,200 per dose respectively.